CCL Products India Rated [ICRA] AA (Stable) for ₹1125.8 Cr Fund-based Facilities
ICRA Limited has assigned credit ratings to CCL Products (India) Limited's bank facilities. Fund-based facilities totaling ₹1155 crore received an [ICRA] AA (Stable) rating, while non-fund-based facilities of ₹45 crore were rated [ICRA] A1+. The total rated amount is ₹1200 crore.
A good credit rating can improve the company's access to debt financing at potentially better terms, facilitating future growth and operations. However, it is a rating of existing facilities and not a new fundraising announcement, hence the medium impact.
The assignment of a stable and high credit rating by ICRA indicates a positive assessment of the company's financial health and creditworthiness, which is beneficial for its borrowing capacity and investor confidence.
CCL Products (India) Limited has received credit ratings from ICRA Limited for its fund-based and non-fund-based bank facilities. The long-term rating for fund-based facilities, including others and term loans, has been assigned as [ICRA] AA (Stable) for a total amount of ₹1125.80 crore and ₹29.20 crore, respectively.
Additionally, the short-term rating for non-fund-based facilities has been assigned as [ICRA] A1+ for ₹45.00 crore. These ratings are in addition to the credit ratings previously disclosed by India Ratings & Research on April 27, 2026.
The detailed breakdown of rated instruments includes various fund-based limits with State Bank of India, Citibank N.A., ICICI Bank Limited, HDFC Bank Limited, Axis Bank Limited, JP Morgan Bank, and DBS Bank Limited, all rated [ICRA] AA (Stable). Non-fund-based facilities with State Bank of India and HDFC Bank Limited are rated [ICRA] A1+. A term loan with Shinhan Bank is also rated [ICRA] AA (Stable). The total amount rated across all instruments is ₹1200.00 crore.
What to do with a filing like this
CCL Products (India) Limited filed this with the NSE as a statutory disclosure, categorised under credit ratings. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by CCL Products (India) Limited. Read the original for the full detail.